Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.64 |
| ▸ | THRB | P10828 | 5/20 | 0.64 |
| ▸ | GAA | P10253 | 4/20 | 0.64 |
| ▸ | LMNA | P02545 | 4/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.64 |
| ▸ | RECQL | P46063 | 3/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.64 |
| ▸ | MEN1 | O00255 | 3/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.64 |
| ▸ | PKM | P14618 | 2/20 | 0.64 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 0.64 |
| ▸ | ABHD5 | Q8WTS1 | 1/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.61 |
| ▸ | ALPG | P10696 | 1/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3294116 | 1.00 | MAPT (0.64) | MAPTTHRBGAALMNASMN1; SMN2 | |
| SCHEMBL8680078 | 0.92 | MAPT (0.74) | MAPTTHRBGAALMNASMN1; SMN2 | |
| SCHEMBL8680159 | 0.83 | MAPT (0.61) | MAPTTHRBGAALMNASMN1; SMN2 | |
| SCHEMBL3287603 | 0.83 | MAPT (0.46) | MAPTTHRBGAALMNASMN1; SMN2 | |
| SCHEMBL3287596 | 0.83 | MAPT (0.46) | MAPTTHRBGAALMNASMN1; SMN2 | |
| SCHEMBL3289455 | 0.82 | MAPT (0.60) | MAPTTHRBGAALMNASMN1; SMN2 | |
| SCHEMBL3289449 | 0.82 | MAPT (0.60) | MAPTTHRBGAALMNASMN1; SMN2 | |
| SCHEMBL8682721 | 0.79 | MAPT (0.56) | MAPTTHRBGAALMNASMN1; SMN2 | |
| SCHEMBL8681722 | 0.78 | MAPT (0.56) | MAPTTHRBGAALMNASMN1; SMN2 | |
| SCHEMBL8684751 | 0.77 | MAPT (0.76) | MAPTTHRBGAALMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7718325-B2 | Photochromic material, inkless reimageable printing paper, and methods | XEROX CORPORATION (US) | 2010-05-18 | — | — | US | disclosed |
| US-7718325-B2 | Photochromic material, inkless reimageable printing paper, and methods | XEROX CORPORATION (US) | 2010-05-18 | — | — | US | disclosed |
| US-7718325-B2 | Photochromic material, inkless reimageable printing paper, and methods | XEROX CORPORATION (US) | 2010-05-18 | — | — | US | disclosed |
| US-20080311495-A1 | PHOTOCHROMIC MATERIAL, INKLESS REIMAGEABLE PRINTING PAPER, AND METHODS | XEROX CORPORATION (US) | 2008-12-18 | — | — | US | disclosed |
| US-20080311495-A1 | PHOTOCHROMIC MATERIAL, INKLESS REIMAGEABLE PRINTING PAPER, AND METHODS | XEROX CORPORATION (US) | 2008-12-18 | — | — | US | disclosed |
| US-20080311495-A1 | PHOTOCHROMIC MATERIAL, INKLESS REIMAGEABLE PRINTING PAPER, AND METHODS | XEROX CORPORATION (US) | 2008-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080311495-A1 | PHOTOCHROMIC MATERIAL, INKLESS REIMAGEABLE PRINTING PAPER, AND METHODS | ILK, RB1, SMCHD1 | MAPT 246/4885THRB 3663/4885GAA 3865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.